Skip to content
November 03, 2026

Equity.Guru

Investment information for the new generation

Search

Pharmaceuticals

10 September 2026 Power Leaves Holdings (NASA.C): Ten bullshit detector questions answered…
10 September 2026
Power Leaves Holdings (NASA.C): Ten bullshit detector questions answered
There are investment pitches that require you to understand geology, biotechnology, or semiconductor architecture. And then there are investment pitches where the first question is, “Hang on. You want to…
7 August 2025 BioNxt (BNXT.C) rips as European Patent Office backs Cladribine…
7 August 2025
BioNxt (BNXT.C) rips as European Patent Office backs Cladribine thin-film
BioNxt Solutions (CSE: BNXT) received a share price boost today after announcing the European Patent Office and its Eurasian counterpart have waved through core claims tied to the company’s…
28 July 2025 NetraMark Holdings (AIAI.C): Failed FDA trials cost billions, NetraAI…
28 July 2025
NetraMark Holdings (AIAI.C): Failed FDA trials cost billions, NetraAI may…
I see a lot of company pitches in my job. I also see a lot of AI pitches. I don’t see a lot of good ones of each. Last…
23 January 2025 Hemostenix (HEMO.V): Bringing back that lovin’ feeling.. and up…
23 January 2025
Hemostenix (HEMO.V): Bringing back that lovin’ feeling.. and up 400%…
Hemostenix (HEM.V) has been lifting off of late, and as we’ve seen some real upward movement in the pharmaceuticals/biotech space in Canada of late (See Onco Innovations and Voyageur…
22 January 2025 Onco Innovations (ONCO.C): What if we could stop cancer…
22 January 2025
Onco Innovations (ONCO.C): What if we could stop cancer coming…
This past month I’ve had three conversations with friends that included the following sentences. “It’s been two years but something doesn’t feel right, I’m going in next week.” “I’m…
9 January 2025 Voyageur Pharmaceuticals (VM) took a mine and turned it…
9 January 2025
Voyageur Pharmaceuticals (VM) took a mine and turned it into…
Quite often, when I talk to mining explorers, I’m left to wonder why their focus is so often on digging things out of the ground and selling the raw…
28 October 2024 Bionxt Solutions (BNXT.C): Seeking to confirm national-level cancer drug…
28 October 2024
Bionxt Solutions (BNXT.C): Seeking to confirm national-level cancer drug patent
As the world increasingly faces the complexities of autoimmune and neurodegenerative diseases, new medical advancements are crucial to better serve patients’ needs. Enter Bionxt Solutions Inc. (BNXT.C), a bioscience…
2 July 2024 BioNxt Solutions (BNXT.C) to spark marketing as ODF human…
2 July 2024
BioNxt Solutions (BNXT.C) to spark marketing as ODF human studies…
Biotech companies are notoriously difficult to find investor love for in Canada, at least historically, so it’s no surprise that BioNxt Solutions (BNXT.C) is headquartered in Germany. That proximity…
12 June 2024 Revive Therapeutics (RVV.CN) provides update on FDA Type C…
12 June 2024
Revive Therapeutics (RVV.CN) provides update on FDA Type C Meeting
              Revive Therapeutics (RVV.V) is a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders….
10 June 2024 Revive Therapeutics (RVV.CN) provides update from FDA meeting Vishal…
10 June 2024
Revive Therapeutics (RVV.CN) provides update from FDA meeting
Revive Therapeutics (RVV.V) is a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders. The company offers cannabinoid pharmaceutical portfolio that…